Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Penicillin refers to a class of antibiotics containing penicillin in the molecule, which can destroy the cell wall of bacteria and play a bactericidal role in the breeding period of bacterial cells. It is an antibiotic extracted from Penicillium. Penicillin belongs to β-lactam antibiotics, and β-lactam antibiotics include penicillin, cephalosporin, carbapenems, monocyclic, and cephalosporins. Penicillin is a very common antibacterial drug. However, an intradermal test must be performed before each use to prevent allergies.
This report focuses on Penicillin Active Pharmaceutical Ingredients.
The global market for Penicillin Active Pharmaceutical Ingredients was estimated to be worth US$ 1827.2 million in 2023 and is forecast to a readjusted size of US$ 1653.5 million by 2030 with a CAGR of -1.4% during the forecast period 2024-2030
Global key players of Penicillin Active Pharmaceutical Ingredients include United Laboratories, Changsheng Pharma, North China Pharmaceutical, Centrient Pharmaceuticals, Aurobindo Pharma and Sinopharm Weiqida Pharmaceutical, etc. Top five players occupy for a share about 50%. Asia-Pacific is the largest market, with a share about 60%, followed by Americas and Europe. In terms of product, Amoxicillin is the largest segment, with a share over 76%. In terms of application, For Oral is the largest market, with a share over 73%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Penicillin Active Pharmaceutical Ingredients, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Penicillin Active Pharmaceutical Ingredients by region & country, by Type, and by Application.
The Penicillin Active Pharmaceutical Ingredients market size, estimations, and forecasts are provided in terms of sales volume (MT) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Penicillin Active Pharmaceutical Ingredients.
Market Segmentation
By Company
Centrient Pharmaceuticals
Jiangxi Fushine Pharmaceutical
Kelun
Harbin Pharmaceutical Group
Changzhou RedSun
Jiangxi Huabang
LKPC
Huaxing Pharma
North China Pharmaceutical
Qilu Tianhe Pharma
Novartis (Sandoz Anti-Infectives)
CSPC Zhongrun
United Laboratories
Sinopharm Weiqida Pharmaceutical
Changsheng Pharma
Aurobindo Pharma
Novartis
ACS Dobfar
Segment by Type
:
Amoxicillin
Piperacillin
Benzylpenicillin Sodium
Ampicillin
Other
Segment by Application
For Oral
For Injection
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Penicillin Active Pharmaceutical Ingredients manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Penicillin Active Pharmaceutical Ingredients in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Penicillin Active Pharmaceutical Ingredients in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
This report focuses on Penicillin Active Pharmaceutical Ingredients.
The global market for Penicillin Active Pharmaceutical Ingredients was estimated to be worth US$ 1827.2 million in 2023 and is forecast to a readjusted size of US$ 1653.5 million by 2030 with a CAGR of -1.4% during the forecast period 2024-2030
Global key players of Penicillin Active Pharmaceutical Ingredients include United Laboratories, Changsheng Pharma, North China Pharmaceutical, Centrient Pharmaceuticals, Aurobindo Pharma and Sinopharm Weiqida Pharmaceutical, etc. Top five players occupy for a share about 50%. Asia-Pacific is the largest market, with a share about 60%, followed by Americas and Europe. In terms of product, Amoxicillin is the largest segment, with a share over 76%. In terms of application, For Oral is the largest market, with a share over 73%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Penicillin Active Pharmaceutical Ingredients, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Penicillin Active Pharmaceutical Ingredients by region & country, by Type, and by Application.
The Penicillin Active Pharmaceutical Ingredients market size, estimations, and forecasts are provided in terms of sales volume (MT) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Penicillin Active Pharmaceutical Ingredients.
Market Segmentation
By Company
Centrient Pharmaceuticals
Jiangxi Fushine Pharmaceutical
Kelun
Harbin Pharmaceutical Group
Changzhou RedSun
Jiangxi Huabang
LKPC
Huaxing Pharma
North China Pharmaceutical
Qilu Tianhe Pharma
Novartis (Sandoz Anti-Infectives)
CSPC Zhongrun
United Laboratories
Sinopharm Weiqida Pharmaceutical
Changsheng Pharma
Aurobindo Pharma
Novartis
ACS Dobfar
Segment by Type
:
Amoxicillin
Piperacillin
Benzylpenicillin Sodium
Ampicillin
Other
Segment by Application
For Oral
For Injection
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Penicillin Active Pharmaceutical Ingredients manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Penicillin Active Pharmaceutical Ingredients in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Penicillin Active Pharmaceutical Ingredients in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
